No Data
TrueCar (NASDAQ:TRUE) Shareholders Have Endured a 54% Loss From Investing in the Stock Three Years Ago
Treatment.com AI Notes Takeover Target Rocket Doctor Expanding in Alberta
Shares of Companies Within the Broader Communication Services Sector Are Trading Lower Amid Economic Worries Driven by Tariffs and Trade Policies. Investors May Be Expecting a Decline in Investment, Which May Also Be Weighing on the Industry.
Treatment.com AI Raises $3 Million in Bought Deal Private Placement
Treatment.com AI Brief: Announced Earlier Tuesday That Rocket Doctor and Its Virtual Healthcare Marketplace Has Been Approved as an In-network Provider for New York Medicaid
BTIG Maintains TrueCar(TRUE.US) With Buy Rating, Maintains Target Price $4
